secwatch.observer — SEC 8-K summary
======================================

Issuer:     4D Molecular Therapeutics, Inc. (FDMT)
CIK:        0001650648
Form:       8-K
Filed at:   2023-05-09T23:59:59+00:00
Accession:  0001193125-23-139482
Event type: other_material
Sentiment:  positive
Materiality: 0.70
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

4D Molecular Therapeutics closes $129.1M public offering of 8.625M shares at $16/share
--------------------------------------------------------------------------------

- Sold 7.5M firm shares plus 1.125M overallotment shares at $16.00 per share, netting ~$129.1M.
- Underwriters include Goldman Sachs, BofA Securities, and Evercore; lock-up restrictions until July 3, 2023.
- Offering closed on May 9, 2023; proceeds for general corporate purposes per shelf registration.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1650648/000119312523139482/0001193125-23-139482-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1650648/000119312523139482/d611852d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-139482

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer